Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.42 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | CDK4 | P11802 | 1/20 | 0.37 |
| ▸ | CCND1 | P24385 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | JUN | P05412 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14993294 | 1.00 | TRIM24 (0.42) | TRIM24TRIM33CA2CA12CA9 | |
| SCHEMBL14993292 | 1.00 | TRIM24 (0.42) | TRIM24TRIM33CA2CA12CA9 | |
| SCHEMBL19428619 | 0.78 | TRIM24 (0.43) | TRIM24TRIM33CA2CA12CA9 | |
| SCHEMBL14992989 | 0.78 | TYR (0.41) | MAPTKDM4EALDH1A1POLBGAA | |
| SCHEMBL14992986 | 0.78 | TYR (0.41) | MAPTKDM4EALDH1A1POLBGAA | |
| SCHEMBL14993714 | 0.78 | TYR (0.41) | MAPTKDM4EALDH1A1POLBGAA | |
| SCHEMBL7896077 | 0.78 | CA2 (0.50) | TRIM24TRIM33CA2CA12CA9 | |
| SCHEMBL18040864 | 0.75 | TRIM24 (0.48) | TRIM24TRIM33CA2CA12CA9 | |
| SCHEMBL14992838 | 0.75 | LMNA (0.46) | CA2CA12CA9MAPTLMNA | |
| SCHEMBL13232745 | 0.75 | LMNA (0.46) | CA2CA12CA9MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2785316-B1 | NITRONE COMPOUNDS FOR USE AS ANTIOXIDANT IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-06-19 | — | — | EP | claimed |
| US-20180071186-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | ROHM AND HAAS COMPANY | 2018-03-15 | — | — | US | claimed |
| US-20180055749-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | ROHM AND HAAS COMPANY | 2018-03-01 | — | — | US | claimed |
| EP-3270876-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | Dow Global Technologies LLC (US) | 2018-01-24 | — | — | EP | claimed |
| EP-3270875-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | Dow Global Technologies LLC (US) | 2018-01-24 | — | — | EP | claimed |
| WO-2016154018-A9 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-05 | — | — | WO | claimed |
| WO-2016154018-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-29 | — | — | WO | claimed |
| WO-2016154022-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-29 | — | — | WO | claimed |
| US-20150335546-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC | 2015-11-26 | — | — | US | claimed |
| US-20140303255-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC | 2014-10-09 | — | — | US | claimed |
| EP-2785316-A2 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | ANGUS Chemical Company (US) | 2014-10-08 | — | — | EP | claimed |
| WO-2013081778-A2 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | ANGUS CHEMICAL COMPANY (US) | 2013-06-06 | — | — | WO | claimed |
| EP-3270876-B1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-12-22 | — | — | EP | disclosed |
| EP-2785316-B1 | NITRONE COMPOUNDS FOR USE AS ANTIOXIDANT IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-06-19 | — | — | EP | disclosed |
| EP-3270875-B1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-05-01 | — | — | EP | disclosed |
| US-10137071-B2 | Nitrone inhibition of oxidation of unsaturated fats | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-11-27 | — | — | US | disclosed |
| US-20150335546-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC | 2015-11-26 | — | — | US | disclosed |
| US-20140303255-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | DOW GLOBAL TECHNOLOGIES LLC | 2014-10-09 | — | — | US | disclosed |
| EP-2785316-A2 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | ANGUS Chemical Company (US) | 2014-10-08 | — | — | EP | disclosed |
| WO-2013081778-A2 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | ANGUS CHEMICAL COMPANY (US) | 2013-06-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303255-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | NOX1, NOX5, NOS1 | TRIM24 1762/4885TRIM33 966/4885CA2 3759/4885 |
| US-10137071-B2 | Nitrone inhibition of oxidation of unsaturated fats | FASN, NDUFB1, FADS1 | TRIM24 4436/4885TRIM33 3951/4885CA2 4176/4885 |
| US-20150335546-A1 | NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE | NOX1, NOX5, NOS1 | TRIM24 1762/4885TRIM33 966/4885CA2 3759/4885 |
| US-20180055749-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | FASN, NDUFB1, FADS1 | TRIM24 4436/4885TRIM33 3951/4885CA2 4176/4885 |
| US-20180071186-A1 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | FASN, TXNRD2, NOS1 | TRIM24 4065/4885TRIM33 3924/4885CA2 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.